应交易所要求,美/港股行情延时15分钟展示,下载APP即可免费查看实时行情。
关闭
TVGNW Tevogen Bio Holdings Inc.
未开盘 07-31 16:00:00 EDT
0.0617
-0.0018
-2.84%
最高
0.0634
最低
0.0586
成交量
1.69万
今开
0.0634
昨收
0.0635
日振幅
7.56%
总市值
0.00
流通市值
0.00
总股本
0.00
成交额
1,046
换手率
--
流通股本
0.00
市净率
--
ROE
--
每股收益
0.00
52周最高
0.1499
52周最低
0.0099
市盈率
--
股息
0.00
股息收益率
0.00
ROA
--
分时
五日
日K
周K
月K
北京优虎网络科技有限公司
资讯
新帖
简况
Tevogen Bio Holdings Inc.盘中异动 快速拉升5.04%报1.25美元
市场透视 · 07-14
Tevogen Bio Holdings Inc.盘中异动 快速拉升5.04%报1.25美元
Tevogen Bio Holdings Inc.盘中异动 股价大涨5.08%报1.24美元
市场透视 · 06-27
Tevogen Bio Holdings Inc.盘中异动 股价大涨5.08%报1.24美元
Tevogen Bio Holdings Inc.盘中异动 早盘股价大跌5.00%
市场透视 · 06-23
Tevogen Bio Holdings Inc.盘中异动 早盘股价大跌5.00%
Tevogen Bio Holdings Inc.盘中异动 临近收盘股价大跌5.22%报1.27美元
市场透视 · 06-12
Tevogen Bio Holdings Inc.盘中异动 临近收盘股价大跌5.22%报1.27美元
Tevogen Bio Holdings Inc.盘中异动 股价大涨5.65%报1.31美元
市场透视 · 06-11
Tevogen Bio Holdings Inc.盘中异动 股价大涨5.65%报1.31美元
Tevogen Bio Holdings Inc.盘中异动 早盘快速下挫5.59%
市场透视 · 06-09
Tevogen Bio Holdings Inc.盘中异动 早盘快速下挫5.59%
Tevogen Bio Holdings Inc.盘中异动 股价大跌5.22%
市场透视 · 05-30
Tevogen Bio Holdings Inc.盘中异动 股价大跌5.22%
Tevogen Bio Holdings Inc.盘中异动 快速上涨6.36%报1.26美元
市场透视 · 05-22
Tevogen Bio Holdings Inc.盘中异动 快速上涨6.36%报1.26美元
Tevogen Bio Holdings Inc.盘中异动 早盘急速下挫5.17%报1.10美元
市场透视 · 05-14
Tevogen Bio Holdings Inc.盘中异动 早盘急速下挫5.17%报1.10美元
Tevogen Bio Holdings Inc.盘中异动 快速上涨5.29%
市场透视 · 05-08
Tevogen Bio Holdings Inc.盘中异动 快速上涨5.29%
Tevogen Bio Holdings Inc.盘中异动 下午盘急速上涨5.94%报1.070美元
市场透视 · 05-05
Tevogen Bio Holdings Inc.盘中异动 下午盘急速上涨5.94%报1.070美元
Tevogen Bio Holdings Inc.盘中异动 早盘股价大涨5.27%
市场透视 · 05-02
Tevogen Bio Holdings Inc.盘中异动 早盘股价大涨5.27%
Tevogen Bio Holdings Inc.盘中异动 早盘急速跳水5.27%
市场透视 · 05-01
Tevogen Bio Holdings Inc.盘中异动 早盘急速跳水5.27%
Tevogen Bio Holdings Inc.盘中异动 早盘大幅跳水5.03%
市场透视 · 04-30
Tevogen Bio Holdings Inc.盘中异动 早盘大幅跳水5.03%
Tevogen Bio Holdings Inc.盘中异动 早盘大幅上涨15.21%报1.080美元
市场透视 · 04-29
Tevogen Bio Holdings Inc.盘中异动 早盘大幅上涨15.21%报1.080美元
Tevogen Bio Holdings Inc.盘中异动 快速拉升5.11%报0.980美元
市场透视 · 04-22
Tevogen Bio Holdings Inc.盘中异动 快速拉升5.11%报0.980美元
Tevogen Bio Holdings Inc.盘中异动 快速下跌5.06%报0.930美元
市场透视 · 04-21
Tevogen Bio Holdings Inc.盘中异动 快速下跌5.06%报0.930美元
Tevogen Bio Holdings Inc.盘中异动 急速下挫5.87%
市场透视 · 04-17
Tevogen Bio Holdings Inc.盘中异动 急速下挫5.87%
Tevogen Bio Holdings Inc.盘中异动 急速拉升5.62%报1.11美元
市场透视 · 04-15
Tevogen Bio Holdings Inc.盘中异动 急速拉升5.62%报1.11美元
Tevogen Bio Holdings Inc.盘中异动 早盘快速跳水5.56%
市场透视 · 04-14
Tevogen Bio Holdings Inc.盘中异动 早盘快速跳水5.56%
加载更多
公司概况
公司名称:
Tevogen Bio Holdings Inc.
所属市场:
NASDAQ
上市日期:
--
主营业务:
Tevogen Bio Holdings Inc.于2021年4月21日在开曼群岛注册成立,后合并重组为特拉华州公司。Tevogen Bio是一家临床阶段的专业免疫疗法公司,利用自然界最强大的免疫武器之一—CD8 +细胞毒性T淋巴细胞,开发现成的、未经基因改造的精准T细胞疗法,用于治疗传染病、癌症和神经系统疾病,旨在解决大量患者群体的重大未满足需求。
发行价格:
--
{"stockData":{"symbol":"TVGNW","market":"US","secType":"STK","nameCN":"Tevogen Bio Holdings Inc.","latestPrice":0.061699,"timestamp":1753992000000,"preClose":0.0635,"halted":0,"volume":16921,"delay":0,"floatShares":0,"shares":0,"eps":0,"marketStatus":"未开盘","change":-0.001801,"latestTime":"07-31 16:00:00 EDT","open":0.0634,"high":0.0634,"low":0.0586,"amount":1045.948772,"amplitude":0.075591,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"ttmEps":0,"tradingStatus":0,"nextMarketStatus":{"tag":"盘前交易","tradingStatus":1,"beginTime":1754035200000},"marketStatusCode":0,"adr":0,"exchange":"NASDAQ","adjPreClose":0.0635,"volumeRatio":0.792048},"requestUrl":"/m/hq/s/TVGNW","defaultTab":"news","newsList":[{"id":"2551872081","title":"Tevogen Bio Holdings Inc.盘中异动 快速拉升5.04%报1.25美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2551872081","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2551872081?lang=zh_cn&edition=full","pubTime":"2025-07-14 22:09","pubTimestamp":1752502167,"startTime":"0","endTime":"0","summary":"北京时间2025年07月14日22时09分,Tevogen Bio Holdings Inc.股票出现异动,股价大幅上涨5.04%。Tevogen Bio Holdings Inc.股票所在的生物技术行业中,整体涨幅为0.95%。Tevogen Bio Holdings Inc.公司简介:Tevogen Bio Holdings Inc 是一家临床阶段的专科免疫治疗公司,利用CD8细胞毒性T淋巴细胞,开发现成的精准T细胞疗法用于治疗传染病、癌症和神经系统疾病。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250714220927a6a9013d&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250714220927a6a9013d&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["TVGN","BK4139","TVGNW"],"gpt_icon":0},{"id":"2546729166","title":"Tevogen Bio Holdings Inc.盘中异动 股价大涨5.08%报1.24美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2546729166","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2546729166?lang=zh_cn&edition=full","pubTime":"2025-06-28 03:55","pubTimestamp":1751054113,"startTime":"0","endTime":"0","summary":"北京时间2025年06月28日03时55分,Tevogen Bio Holdings Inc.股票出现异动,股价快速上涨5.08%。截至发稿,该股报1.24美元/股,成交量54.4329万股,换手率0.30%,振幅8.05%。Tevogen Bio Holdings Inc.股票所在的生物技术行业中,整体跌幅为0.84%。Tevogen Bio Holdings Inc.公司简介:Tevogen Bio Holdings Inc 是一家临床阶段的专科免疫治疗公司,利用CD8细胞毒性T淋巴细胞,开发现成的精准T细胞疗法用于治疗传染病、癌症和神经系统疾病。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250628035513a4c1cba0&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250628035513a4c1cba0&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","TVGN","TVGNW"],"gpt_icon":0},{"id":"2545417378","title":"Tevogen Bio Holdings Inc.盘中异动 早盘股价大跌5.00%","url":"https://stock-news.laohu8.com/highlight/detail?id=2545417378","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2545417378?lang=zh_cn&edition=full","pubTime":"2025-06-23 21:31","pubTimestamp":1750685499,"startTime":"0","endTime":"0","summary":"北京时间2025年06月23日21时31分,Tevogen Bio Holdings Inc.股票出现异动,股价快速下挫5.00%。截至发稿,该股报1.14美元/股,成交量9.8243万股,换手率0.05%,振幅0.00%。Tevogen Bio Holdings Inc.股票所在的生物技术行业中,整体涨幅为0.30%。Tevogen Bio Holdings Inc.公司简介:Tevogen Bio Holdings Inc 是一家临床阶段的专科免疫治疗公司,利用CD8细胞毒性T淋巴细胞,开发现成的精准T细胞疗法用于治疗传染病、癌症和神经系统疾病。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250623213139a718f0c2&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250623213139a718f0c2&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["TVGN","TVGNW","BK4139"],"gpt_icon":0},{"id":"2543254405","title":"Tevogen Bio Holdings Inc.盘中异动 临近收盘股价大跌5.22%报1.27美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2543254405","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2543254405?lang=zh_cn&edition=full","pubTime":"2025-06-13 03:37","pubTimestamp":1749757031,"startTime":"0","endTime":"0","summary":"北京时间2025年06月13日03时37分,Tevogen Bio Holdings Inc.股票出现波动,股价急速跳水5.22%。截至发稿,该股报1.27美元/股,成交量48.2294万股,换手率0.26%,振幅5.97%。Tevogen Bio Holdings Inc.股票所在的生物技术行业中,整体涨幅为0.73%。Tevogen Bio Holdings Inc.公司简介:Tevogen Bio Holdings Inc 是一家临床阶段的专科免疫治疗公司,利用CD8细胞毒性T淋巴细胞,开发现成的精准T细胞疗法用于治疗传染病、癌症和神经系统疾病。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250613033711a705e614&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250613033711a705e614&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["TVGN","TVGNW","BK4139"],"gpt_icon":0},{"id":"2542953972","title":"Tevogen Bio Holdings Inc.盘中异动 股价大涨5.65%报1.31美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2542953972","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2542953972?lang=zh_cn&edition=full","pubTime":"2025-06-12 01:03","pubTimestamp":1749661425,"startTime":"0","endTime":"0","summary":"北京时间2025年06月12日01时03分,Tevogen Bio Holdings Inc.股票出现异动,股价快速上涨5.65%。截至发稿,该股报1.31美元/股,成交量32.4082万股,换手率0.18%,振幅5.65%。Tevogen Bio Holdings Inc.股票所在的生物技术行业中,整体涨幅为0.62%。Tevogen Bio Holdings Inc.公司简介:Tevogen Bio Holdings Inc 是一家临床阶段的专科免疫治疗公司,利用CD8细胞毒性T淋巴细胞,开发现成的精准T细胞疗法用于治疗传染病、癌症和神经系统疾病。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250612010345a4a3c9ba&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250612010345a4a3c9ba&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["TVGNW","TVGN","BK4139"],"gpt_icon":0},{"id":"2542771380","title":"Tevogen Bio Holdings Inc.盘中异动 早盘快速下挫5.59%","url":"https://stock-news.laohu8.com/highlight/detail?id=2542771380","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2542771380?lang=zh_cn&edition=full","pubTime":"2025-06-09 21:39","pubTimestamp":1749476364,"startTime":"0","endTime":"0","summary":"北京时间2025年06月09日21时39分,Tevogen Bio Holdings Inc.股票出现波动,股价快速下跌5.59%。截至发稿,该股报1.35美元/股,成交量10.0639万股,换手率0.05%,振幅4.90%。Tevogen Bio Holdings Inc.股票所在的生物技术行业中,整体涨幅为0.66%。Tevogen Bio Holdings Inc.公司简介:Tevogen Bio Holdings Inc 一家临床阶段的专业免疫治疗公司,利用 CD8+ 细胞毒性 T 淋巴细胞开发现成的精准 T 细胞疗法,用于治疗传染病、癌症和神经系统疾病。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202506092139259514d65c&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202506092139259514d65c&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["TVGNW","TVGN","BK4139"],"gpt_icon":0},{"id":"2539427100","title":"Tevogen Bio Holdings Inc.盘中异动 股价大跌5.22%","url":"https://stock-news.laohu8.com/highlight/detail?id=2539427100","media":"市场透视","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2539427100?lang=zh_cn&edition=full","pubTime":"2025-05-31 00:58","pubTimestamp":1748624284,"startTime":"0","endTime":"0","summary":"北京时间2025年05月31日00时58分,Tevogen Bio Holdings Inc.股票出现异动,股价大幅下跌5.22%。截至发稿,该股报1.27美元/股,成交量139.662万股,换手率0.76%,振幅8.96%。Tevogen Bio Holdings Inc.股票所在的生物技术行业中,整体跌幅为4.44%。Tevogen Bio Holdings Inc.公司简介:Tevogen Bio Holdings Inc 一家临床阶段的专业免疫治疗公司,利用 CD8+ 细胞毒性 T 淋巴细胞开发现成的精准 T 细胞疗法,用于治疗传染病、癌症和神经系统疾病。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250531005804a6f39ceb&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250531005804a6f39ceb&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["TVGNW","TVGN","BK4139"],"gpt_icon":0},{"id":"2537247559","title":"Tevogen Bio Holdings Inc.盘中异动 快速上涨6.36%报1.26美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2537247559","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2537247559?lang=zh_cn&edition=full","pubTime":"2025-05-23 04:01","pubTimestamp":1747944062,"startTime":"0","endTime":"0","summary":"北京时间2025年05月23日04时01分,Tevogen Bio Holdings Inc.股票出现波动,股价快速上涨6.36%。截至发稿,该股报1.26美元/股,成交量47.9705万股,换手率0.26%,振幅6.78%。Tevogen Bio Holdings Inc.股票所在的生物技术行业中,整体跌幅为0.46%。Tevogen Bio Holdings Inc.公司简介:Tevogen Bio Holdings Inc 一家临床阶段的专业免疫治疗公司,利用 CD8+ 细胞毒性 T 淋巴细胞开发现成的精准 T 细胞疗法,用于治疗传染病、癌症和神经系统疾病。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025052304010394ff7e8e&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025052304010394ff7e8e&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["TVGNW","BK4139","TVGN"],"gpt_icon":0},{"id":"2535071719","title":"Tevogen Bio Holdings Inc.盘中异动 早盘急速下挫5.17%报1.10美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2535071719","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2535071719?lang=zh_cn&edition=full","pubTime":"2025-05-14 23:24","pubTimestamp":1747236240,"startTime":"0","endTime":"0","summary":"北京时间2025年05月14日23时24分,Tevogen Bio Holdings Inc.股票出现波动,股价大幅下挫5.17%。截至发稿,该股报1.10美元/股,成交量17.8042万股,换手率0.10%,振幅4.76%。Tevogen Bio Holdings Inc.股票所在的生物技术行业中,整体跌幅为0.95%。Tevogen Bio Holdings Inc.公司简介:Tevogen Bio Holdings Inc 一家临床阶段的专业免疫治疗公司,利用 CD8+ 细胞毒性 T 淋巴细胞开发现成的精准 T 细胞疗法,用于治疗传染病、癌症和神经系统疾病。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025051423240097599b53&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025051423240097599b53&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["TVGNW","TVGN","BK4139"],"gpt_icon":0},{"id":"2533539071","title":"Tevogen Bio Holdings Inc.盘中异动 快速上涨5.29%","url":"https://stock-news.laohu8.com/highlight/detail?id=2533539071","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2533539071?lang=zh_cn&edition=full","pubTime":"2025-05-08 23:43","pubTimestamp":1746718986,"startTime":"0","endTime":"0","summary":"北京时间2025年05月08日23时43分,Tevogen Bio Holdings Inc.股票出现波动,股价急速上涨5.29%。截至发稿,该股报1.10美元/股,成交量18.8065万股,换手率0.10%,振幅5.29%。Tevogen Bio Holdings Inc.股票所在的生物技术行业中,整体跌幅为2.55%。Tevogen Bio Holdings Inc.公司简介:Tevogen Bio Holdings Inc 一家临床阶段的专业免疫治疗公司,利用 CD8+ 细胞毒性 T 淋巴细胞开发现成的精准 T 细胞疗法,用于治疗传染病、癌症和神经系统疾病。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202505082343079753646e&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202505082343079753646e&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["TVGN","BK4139","TVGNW"],"gpt_icon":0},{"id":"2533552365","title":"Tevogen Bio Holdings Inc.盘中异动 下午盘急速上涨5.94%报1.070美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2533552365","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2533552365?lang=zh_cn&edition=full","pubTime":"2025-05-06 01:10","pubTimestamp":1746465029,"startTime":"0","endTime":"0","summary":"北京时间2025年05月06日01时10分,Tevogen Bio Holdings Inc.股票出现波动,股价大幅上涨5.94%。截至发稿,该股报1.070美元/股,成交量28.6442万股,换手率0.16%,振幅7.62%。Tevogen Bio Holdings Inc.股票所在的生物技术行业中,整体涨幅为0.35%。Tevogen Bio Holdings Inc.公司简介:Tevogen Bio Holdings Inc 一家临床阶段的专业免疫治疗公司,利用 CD8+ 细胞毒性 T 淋巴细胞开发现成的精准 T 细胞疗法,用于治疗传染病、癌症和神经系统疾病。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250506011029aa2c8357&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250506011029aa2c8357&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["TVGNW","BK4139","TVGN"],"gpt_icon":0},{"id":"2532352825","title":"Tevogen Bio Holdings Inc.盘中异动 早盘股价大涨5.27%","url":"https://stock-news.laohu8.com/highlight/detail?id=2532352825","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2532352825?lang=zh_cn&edition=full","pubTime":"2025-05-02 23:08","pubTimestamp":1746198539,"startTime":"0","endTime":"0","summary":"北京时间2025年05月02日23时08分,Tevogen Bio Holdings Inc.股票出现异动,股价急速上涨5.27%。截至发稿,该股报1.030美元/股,成交量30.2157万股,换手率0.16%,振幅5.25%。Tevogen Bio Holdings Inc.股票所在的生物技术行业中,整体涨幅为1.16%。Tevogen Bio Holdings Inc.公司简介:Tevogen Bio Holdings Inc 一家临床阶段的专业免疫治疗公司,利用 CD8+ 细胞毒性 T 淋巴细胞开发现成的精准 T 细胞疗法,用于治疗传染病、癌症和神经系统疾病。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250502230859974d7285&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250502230859974d7285&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["TVGN","TVGNW","BK4139"],"gpt_icon":0},{"id":"2532600591","title":"Tevogen Bio Holdings Inc.盘中异动 早盘急速跳水5.27%","url":"https://stock-news.laohu8.com/highlight/detail?id=2532600591","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2532600591?lang=zh_cn&edition=full","pubTime":"2025-05-01 22:05","pubTimestamp":1746108351,"startTime":"0","endTime":"0","summary":"北京时间2025年05月01日22时05分,Tevogen Bio Holdings Inc.股票出现波动,股价快速下跌5.27%。Tevogen Bio Holdings Inc.股票所在的生物技术行业中,整体跌幅为0.77%。Tevogen Bio Holdings Inc.公司简介:Tevogen Bio Holdings Inc 一家临床阶段的专业免疫治疗公司,利用 CD8+ 细胞毒性 T 淋巴细胞开发现成的精准 T 细胞疗法,用于治疗传染病、癌症和神经系统疾病。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025050122055194e9fb25&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025050122055194e9fb25&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["TVGN","TVGNW","BK4139"],"gpt_icon":0},{"id":"2531005866","title":"Tevogen Bio Holdings Inc.盘中异动 早盘大幅跳水5.03%","url":"https://stock-news.laohu8.com/highlight/detail?id=2531005866","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2531005866?lang=zh_cn&edition=full","pubTime":"2025-04-30 21:33","pubTimestamp":1746019991,"startTime":"0","endTime":"0","summary":"北京时间2025年04月30日21时33分,Tevogen Bio Holdings Inc.股票出现异动,股价大幅跳水5.03%。截至发稿,该股报0.959美元/股,成交量35.6348万股,换手率0.19%,振幅3.24%。Tevogen Bio Holdings Inc.股票所在的生物技术行业中,整体涨幅为0.30%。Tevogen Bio Holdings Inc.公司简介:Tevogen Bio Holdings Inc 一家临床阶段的专业免疫治疗公司,利用 CD8+ 细胞毒性 T 淋巴细胞开发现成的精准 T 细胞疗法,用于治疗传染病、癌症和神经系统疾病。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250430213311974ba08c&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250430213311974ba08c&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["TVGN","TVGNW","BK4139"],"gpt_icon":0},{"id":"2531737522","title":"Tevogen Bio Holdings Inc.盘中异动 早盘大幅上涨15.21%报1.080美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2531737522","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2531737522?lang=zh_cn&edition=full","pubTime":"2025-04-29 21:31","pubTimestamp":1745933514,"startTime":"0","endTime":"0","summary":"北京时间2025年04月29日21时31分,Tevogen Bio Holdings Inc.股票出现异动,股价急速上涨15.21%。截至发稿,该股报1.080美元/股,成交量658.922万股,换手率3.58%,振幅4.29%。Tevogen Bio Holdings Inc.股票所在的生物技术行业中,整体跌幅为1.78%。Tevogen Bio Holdings Inc.公司简介:Tevogen Bio Holdings Inc 一家临床阶段的专业免疫治疗公司,利用 CD8+ 细胞毒性 T 淋巴细胞开发现成的精准 T 细胞疗法,用于治疗传染病、癌症和神经系统疾病。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250429213154a6cd6993&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250429213154a6cd6993&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["TVGNW","BK4139","TVGN"],"gpt_icon":0},{"id":"2529553473","title":"Tevogen Bio Holdings Inc.盘中异动 快速拉升5.11%报0.980美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2529553473","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2529553473?lang=zh_cn&edition=full","pubTime":"2025-04-23 00:37","pubTimestamp":1745339873,"startTime":"0","endTime":"0","summary":"北京时间2025年04月23日00时37分,Tevogen Bio Holdings Inc.股票出现异动,股价大幅上涨5.11%。截至发稿,该股报0.980美元/股,成交量14.3263万股,换手率0.08%,振幅3.51%。Tevogen Bio Holdings Inc.股票所在的生物技术行业中,整体涨幅为2.05%。Tevogen Bio Holdings Inc.公司简介:Tevogen Bio Holdings Inc 一家临床阶段的专业免疫治疗公司,利用 CD8+ 细胞毒性 T 淋巴细胞开发现成的精准 T 细胞疗法,用于治疗传染病、癌症和神经系统疾病。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025042300375394de5f3b&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025042300375394de5f3b&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","TVGNW","TVGN"],"gpt_icon":0},{"id":"2529365553","title":"Tevogen Bio Holdings Inc.盘中异动 快速下跌5.06%报0.930美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2529365553","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2529365553?lang=zh_cn&edition=full","pubTime":"2025-04-22 01:17","pubTimestamp":1745255825,"startTime":"0","endTime":"0","summary":"北京时间2025年04月22日01时17分,Tevogen Bio Holdings Inc.股票出现波动,股价大幅下跌5.06%。截至发稿,该股报0.930美元/股,成交量13.6958万股,换手率0.07%,振幅3.81%。Tevogen Bio Holdings Inc.股票所在的生物技术行业中,整体跌幅为0.49%。Tevogen Bio Holdings Inc.公司简介:Tevogen Bio Holdings Inc 一家临床阶段的专业免疫治疗公司,利用 CD8+ 细胞毒性 T 淋巴细胞开发现成的精准 T 细胞疗法,用于治疗传染病、癌症和神经系统疾病。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250422011705a4615957&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250422011705a4615957&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","TVGN","TVGNW"],"gpt_icon":0},{"id":"2528741021","title":"Tevogen Bio Holdings Inc.盘中异动 急速下挫5.87%","url":"https://stock-news.laohu8.com/highlight/detail?id=2528741021","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2528741021?lang=zh_cn&edition=full","pubTime":"2025-04-17 22:20","pubTimestamp":1744899645,"startTime":"0","endTime":"0","summary":"北京时间2025年04月17日22时20分,Tevogen Bio Holdings Inc.股票出现波动,股价大幅跳水5.87%。截至发稿,该股报0.960美元/股,成交量5.744万股,换手率0.03%,振幅4.55%。Tevogen Bio Holdings Inc.股票所在的生物技术行业中,整体涨幅为0.44%。Tevogen Bio Holdings Inc.公司简介:Tevogen Bio Holdings Inc 一家临床阶段的专业免疫治疗公司,利用 CD8+ 细胞毒性 T 淋巴细胞开发现成的精准 T 细胞疗法,用于治疗传染病、癌症和神经系统疾病。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025041722204594d8de62&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025041722204594d8de62&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["TVGNW","TVGN","BK4139"],"gpt_icon":0},{"id":"2527429586","title":"Tevogen Bio Holdings Inc.盘中异动 急速拉升5.62%报1.11美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2527429586","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2527429586?lang=zh_cn&edition=full","pubTime":"2025-04-16 02:21","pubTimestamp":1744741260,"startTime":"0","endTime":"0","summary":"北京时间2025年04月16日02时21分,Tevogen Bio Holdings Inc.股票出现异动,股价大幅上涨5.62%。截至发稿,该股报1.11美元/股,成交量29.3171万股,换手率0.16%,振幅7.62%。Tevogen Bio Holdings Inc.股票所在的生物技术行业中,整体跌幅为0.74%。Tevogen Bio Holdings Inc.公司简介:Tevogen Bio Holdings Inc 一家临床阶段的专业免疫治疗公司,利用 CD8+ 细胞毒性 T 淋巴细胞开发现成的精准 T 细胞疗法,用于治疗传染病、癌症和神经系统疾病。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250416022101a45a0a01&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250416022101a45a0a01&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","TVGN","TVGNW"],"gpt_icon":0},{"id":"2527191272","title":"Tevogen Bio Holdings Inc.盘中异动 早盘快速跳水5.56%","url":"https://stock-news.laohu8.com/highlight/detail?id=2527191272","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2527191272?lang=zh_cn&edition=full","pubTime":"2025-04-14 23:20","pubTimestamp":1744644034,"startTime":"0","endTime":"0","summary":"北京时间2025年04月14日23时20分,Tevogen Bio Holdings Inc.股票出现波动,股价大幅下跌5.56%。截至发稿,该股报1.02美元/股,成交量23.9569万股,换手率0.13%,振幅4.63%。Tevogen Bio Holdings Inc.股票所在的生物技术行业中,整体涨幅为2.33%。Tevogen Bio Holdings Inc.公司简介:Tevogen Bio Holdings Inc 一家临床阶段的专业免疫治疗公司,利用 CD8+ 细胞毒性 T 淋巴细胞开发现成的精准 T 细胞疗法,用于治疗传染病、癌症和神经系统疾病。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250414232034a458a260&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250414232034a458a260&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["TVGN","TVGNW","BK4139"],"gpt_icon":0}],"profile":{"websiteUrl":"http://semperparatusspac.com","stockEarnings":[{"period":"1week","weight":0.0165},{"period":"1month","weight":-0.1071},{"period":"3month","weight":0.2962},{"period":"6month","weight":-0.2655},{"period":"1year","weight":2.4277},{"period":"ytd","weight":0.1426}],"compareEarnings":[{"period":"1week","weight":-0.0037},{"period":"1month","weight":0.0234},{"period":"3month","weight":0.1153},{"period":"6month","weight":0.0503},{"period":"1year","weight":0.1475},{"period":"ytd","weight":0.0785}],"compareStock":{"symbol":"SPY","name":"标普500ETF"},"description":"Tevogen Bio Holdings Inc.于2021年4月21日在开曼群岛注册成立,后合并重组为特拉华州公司。Tevogen Bio是一家临床阶段的专业免疫疗法公司,利用自然界最强大的免疫武器之一—CD8 +细胞毒性T淋巴细胞,开发现成的、未经基因改造的精准T细胞疗法,用于治疗传染病、癌症和神经系统疾病,旨在解决大量患者群体的重大未满足需求。","yearOnYearQuotes":[{"month":1,"riseRate":1,"avgChangeRate":1.578518},{"month":2,"riseRate":0.25,"avgChangeRate":0.208292},{"month":3,"riseRate":0.5,"avgChangeRate":-0.000591},{"month":4,"riseRate":0.25,"avgChangeRate":-0.197994},{"month":5,"riseRate":0.25,"avgChangeRate":-0.093258},{"month":6,"riseRate":0.25,"avgChangeRate":-0.057785},{"month":7,"riseRate":0.25,"avgChangeRate":-0.074125},{"month":8,"riseRate":0.333333,"avgChangeRate":0.1125},{"month":9,"riseRate":0,"avgChangeRate":-0.256349},{"month":10,"riseRate":0.333333,"avgChangeRate":1.818294},{"month":11,"riseRate":0,"avgChangeRate":-0.508558},{"month":12,"riseRate":0.333333,"avgChangeRate":0.083737}],"exchange":"NASDAQ","name":"Tevogen Bio Holdings Inc.","nameEN":"Tevogen Bio Holdings Inc."},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"deviceId":"web-server-community-laohu8-v3","version":"4.34.4","shortVersion":"4.34.4","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"Tevogen Bio Holdings Inc.(TVGNW)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供Tevogen Bio Holdings Inc.(TVGNW)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"Tevogen Bio Holdings Inc.,TVGNW,Tevogen Bio Holdings Inc.股票,Tevogen Bio Holdings Inc.股票老虎,Tevogen Bio Holdings Inc.股票老虎国际,Tevogen Bio Holdings Inc.行情,Tevogen Bio Holdings Inc.股票行情,Tevogen Bio Holdings Inc.股价,Tevogen Bio Holdings Inc.股市,Tevogen Bio Holdings Inc.股票价格,Tevogen Bio Holdings Inc.股票交易,Tevogen Bio Holdings Inc.股票购买,Tevogen Bio Holdings Inc.股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"Tevogen Bio Holdings Inc.(TVGNW)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供Tevogen Bio Holdings Inc.(TVGNW)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}